ascendis pharma Ascendis Pharma A/S Cautionary Note On Forward-Looking Statements This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, such as statements regarding our future results of operations and financial position, including our business strategy, prospective products, availability of funding, clinical trial results, product approvals and regulatory pathways, collaborations, licensing or other arrangements, the ...

Ascendis Pharma A/S (ASND) Q1 2020 Earnings Conference Call May 19, 2020 4:30 PM ET Company Participants Scott Smith - Senior Vice President and Chief Financial Officer Jan Mikkelsen - Chief Executive Officer Dana Pizzuti - Head, Development Operations Juha Punnonen - Head, Oncology Conference Call Participants Tazeen Ahmad - Bank of America Michelle Gilson - Canaccord David Lebowitz - Morgan Stanley Josh Schimmer - Evercore ISI Alethia Young - Cantor Fitzgerald Jim Birchenough - Wells Fargo Tiago Fauth - C ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTI ...

Ascendis Pharma A/S (ASND) Q4 2019 Earnings Conference Call April 1, 2020 4:30 PM ET Company Participants Scott Smith - Senior Vice President and Chief Financial Officer Jan Mikkelsen - President and Chief Executive Officer Tom Larson - Chief Commercial Officer Juha Punnonen - Head, Oncology Dana Pizzuti - Head, Development Operations Conference Call Participants Jessica Fye - JPMorgan Tazeen Ahmad - Bank of America Michelle Gilson - Canaccord Genuity David Lebowitz - Morgan Stanley Jim Birchenough - Wells ...

Ascendis Pharma A/S (ASND) Q3 2019 Earnings Conference Call November 15, 2019 4:30 PM ET Company Participants Scott Smith - SVP and CFO Jan Mikkelsen - President and CEO Juha Punnonen - Head of Oncology Dana Pizzuti - Head of Development Operations Conference Call Participants Jessica Fye - JP Morgan Alethia Young - Cantor Fitzgerald Tazeen Ahmad - Bank of America Merrill Lynch David Lebowitz - Morgan Stanley Michelle Gilson - Canaccord Liana Moussatos - Wedbush Securities Josh Schimmer - Evercore ISI Josep ...

Ascendis Pharma A/S (ASND) Q2 2019 Results Earnings Conference Call August 28, 2019 4:30 PM ET Company Participants Jan Mikkelsen - President and Chief Executive Officer Dr. Jonathan Leff - Chief Medical Officer Scott Smith - SVP and Chief Financial Officer Tom Larson - Chief Commercial Officer Juha Punnonen - Head of Oncology Conference Call Participants Josh Schimmer - Evercore Tazeen Ahmad - Bank of America Merrill Lynch Jessica Fye - JPMorgan Michelle Gilson - Canaccord Genuity Jim Birchenough - Wells F ...

Ascendis Pharma A/S (ASND) Q1 2019 Earnings Conference Call May 30, 2019 4:30 PM ET Company Participants Scott Smith - Senior Vice President & Chief Financial Officer Jan Mikkelsen - President & Chief Executive Officer Jonathan Leff - Chief Medical Officer Conference Call Participants Tazeen Ahmad - Bank of America Merrill Lynch Jessica Fye - JPMorgan Michelle Gilson - Canaccord Genuity Adam Walsh - Stifel Alethia Young - Cantor Fitzgerald Operator Good day, ladies and gentlemen, and welcome to the First Qu ...